🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Joan Jacob

Baylor College of Medicine

ORCID: 0000-0002-9756-8449
Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “The Hippo Pathway in Cardiac Regeneration and Homeostasis: New Perspectives for Cell-Free Therapy in the Injured Heart”.

The Hippo Pathway in Cardiac Regeneration and Homeostasis: New Perspectives for Cell-Free Therapy in the Injured Heart

Biomolecules(2020)10.3390/biom10071024
N/A
0DataRank · unranked
29 citations

Joan Jacob, Shao-Hsi Hung, Jun Wang, Mingjie Zheng

Anti-GPR56 monoclonal antibody potentiates GPR56-mediated Src-Fak signaling to modulate cell adhesion

Journal of Biological Chemistry(2021)10.1016/j.jbc.2021.100261
N/A
0DataRank · unranked
34 citations

Sheng Zhang, Tressie A. Posey, Joan Jacob, Ling Wu, Wangsheng Yu +4 more

An antibody-drug conjugate targeting GPR56 demonstrates efficacy in preclinical models of colorectal cancer

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.08.11.503187
N/A
0DataRank · unranked
10 citations

Liezl E. Francisco, Treena Chatterjee, Zhengdong Liang, Shraddha Subramanian, Qingyun J. Liu +3 more

Loss of LGR5 through plasticity or gene ablation is associated with therapy resistance and enhanced MET-STAT3 signaling in colorectal cancer cells

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.01.482539
N/A
0DataRank · unranked
2 citations

Joan Jacob, Ashlyn Parkhurst, Shraddha Subramanian, Liezl E. Francisco, Zhengdong Liang +2 more

Development of a Novel Combination Therapy targeting MET and LGR5 to overcome Colorectal Cancer Resistance

(2022)10.52519/00086
N/A
0DataRank · unranked
2 citations

Tressie A. Posey, Joan Jacob, Kendra S. Carmon, Shradhha Subramanian

An antibody–drug conjugate targeting GPR56 demonstrates efficacy in preclinical models of colorectal cancer

British Journal of Cancer(2023)10.1038/s41416-023-02192-3
N/A
0DataRank · unranked
24 citations

Liezl E. Francisco, Treena Chatterjee, Zhengdong Liang, Shraddha Subramanian, Qingyun J. Liu +3 more

Loss of LGR5 through Therapy-induced Downregulation or Gene Ablation Is Associated with Resistance and Enhanced MET-STAT3 Signaling in Colorectal Cancer Cells

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-22-0415
N/A
0DataRank · unranked
17 citations

Joan Jacob, Ashlyn Parkhurst, Shraddha Subramanian, Liezl E. Francisco, Zhengdong Liang +2 more

G protein selectivity profile of GPR56/ADGRG1 and its effect on downstream effectors

Cellular and Molecular Life Sciences(2024)10.1007/s00018-024-05416-8
N/A
0DataRank · unranked
8 citations

Ana L. Moreno-Salinas, Andréanne Laniel, Brian J. Holleran, Charlotte Avet, Joan Jacob +6 more

The Evolving Paradigm of Antibody–Drug Conjugates Targeting the ErbB/HER Family of Receptor Tyrosine Kinases

Pharmaceutics(2024)10.3390/pharmaceutics16070890
N/A
0DataRank · unranked
14 citations

Cara Guernsey-Biddle, Shraddha Subramanian, Joan Jacob, Kendra S. Carmon, Peyton C. High

Antitumor Activity of a Pyrrolobenzodiazepine Antibody–Drug Conjugate Targeting LGR5 in Preclinical Models of Neuroblastoma

Pharmaceutics(2024)10.3390/pharmaceutics16070943
N/A
0DataRank · unranked
10 citations

Yukimatsu Toh, Adela M. Aldana, Jake J. Wen, Ling Wu, Joan Jacob +5 more

G protein selectivity profile of GPR56/ADGRG1 and its effect on downstream effectors

Research square(2024)10.21203/rs.3.rs-4869264/v1
N/A
0DataRank · unranked
0 citations

Ana Lilia Moreno Salinas, Andréanne Laniel, Brian J. Holleran, Charlotte Avet, Joan Jacob +6 more